XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Stockholders’ Equity

10. Stockholders’ Equity

 

Common Stock

 

As of September 30, 2024, 4,230,806 shares of common stock were issued and outstanding, 255,958 shares of common stock were reserved for issuance upon the exercise of outstanding warrants, 612,952 shares of common stock were reserved for issuance under our 2015 Equity Incentive Plan, as amended (the “2015 Plan”), and our 2025 Equity Incentive Plans, as amended (the “2025 Plan”), and 110,136 shares were reserved for issuance under our 2023 Non-Employee Director Compensation Plan.

 

The following table describes the shares and warrants issued as part of our 2022 private placement:

 

Issuance of Common Stock  Issue Date  Shares
Issued		   Price per
share		   Warrants
Issued		   Warrant
Exercise
Price		   Warrant
Fair
Value		 
Private Placement 2022  April 1, 2022   1,242,588   $4.62    124,258   $4.62   $3.91 

 

Amortization of the debt issuance costs for the Private Placement 2022 offering was recorded at $47,559 and $142,091 for the three and nine months ended September 30, 2024, and at $38,931 and $116,793 for the three and nine months ended September 30, 2023.

 

Warrants

 

The following sets forth the warrants to purchase our common stock that were outstanding as of September 30, 2024:

 

Warrants Outstanding   Warrant
Exercise Price		   Warranty Expiry
 124,258   $4.62   March 30, 2027
 95,500   $4.00   March 30, 2027
 16,000   $9.00   March 30, 2027
 17,200   $12.50   March 30, 2027
 3,000   $15.00   March 30, 2027